Back to Results

Brigatinib Before Brain Irradiation Trial (B3i Trial): A Phase II Trial of Brigatinib Alone for Brain Metastases from ALK+ Lung Cancer

Study category: Cancer

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Type of Study

Treatment

Locations

City of Hope Cancer Center
Mayo Clinic, Rochester
University of Colorado Hospital

Principal Investigator
Chad Rusthoven,  MD

Chad Rusthoven, MD

Study ID

Protocol Number: 19-2862

More information available at ClinicalTrials.gov: NCT04634110

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers